Methandriol dipropionate
| Clinical data | |
|---|---|
| Trade names | Arbolic, Durabolic, Or-Bolic, Probolik, Protabolin | 
| Other names | Methylandrostenediol dipropionate; Methylandrostenediol 3β,17β-dipropionate; MADP; 17α-Methylandrost-5-ene-3β,17β-diol 3,17β-dipropionate | 
| Routes of administration | Intramuscular injection | 
| Drug class | Androgen; Anabolic steroid; Androgen ester | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.020.669 | 
| Chemical and physical data | |
| Formula | C26H40O4 | 
| Molar mass | 416.602 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Methandriol dipropionate (MADP), also known as methylandrostenediol dipropionate and sold under the brand names Arbolic, Durabolic, Or-Bolic, Probolik, and Protabolin among others, is a synthetic, injected anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 5-androstenediol. It is an androgen ester – specifically, the C3,17β dipropionate ester of methandriol (17α-methyl-5-androstenediol) – and acts as a prodrug of methandriol in the body. Methandriol dipropionate is administered by intramuscular injection and, relative to methandriol, has an extended duration via this route of several days due to a depot effect afforded by its ester. It was marketed in the United States, but is no longer available in this country.